对比不同类型肝素的生物活性
1Loyola University Chicago, Cardiovascular Research Institute, Maywood, IL, USA. wjeske@luc.edu.
Handbook of experimental pharmacology
|December 15, 2025
概括
对猪肝素供应的担忧正在推动研究替代来源,如奶牛和绵羊肠道. 这些替代性肝素在治疗血栓状况方面具有独特的生物特性.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 兽医医学 兽医医学 兽医医学
背景情况:
- 氨酸和低分子量氨酸衍生物对于预防和治疗血栓状况至关重要.
- 目前的肝素生产严重依赖猪肠道粘膜,引发了对供应稳定性和充足性的担忧.
- 由于这些供应链漏洞,正在探索氨酸的替代来源.
研究的目的:
- 探索除了猪肠粘膜之外的替代性肝素来源.
- 总结一下当前对来自各种动物物种的肝素的理解.
- 突出生物衍生肝素的独特结构和功能特征.
主要方法:
- 审查关于肝素来源的现有文献.
- 标识产生的氨酸或氨酸类材料的商业数量物种.
- 分析非猪类肝素的结构和功能特征.
主要成果:
- 商用氨酸可以从牛和绵羊的肠道中获取.
- 在其他各种动物物种中发现了氨酸或氨酸类物质.
- 来自不同生物来源的肝素具有不同的结构和功能性质.
结论:
- 其他动物来源,如牛和羊,可以提供商业化数量的肝素.
- 肝素的生物起源影响其独特的结构和功能特性.
- 对这些多样化的肝素来源进行进一步的研究对于药物应用是有必要的.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Bioequivalence: Overview
1.6K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Equivalence: In Vitro and In Vivo Bioequivalence
193
Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
193
Bioequivalence Data: Statistical Interpretation
181
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
181


